H-Tyr(Bzl)-OBzl·Tos CAS:66009-35-6
I ka synthesis peptide, hana ʻo H-Tyr(Bzl)-OBzl·Tos ma ke ʻano he derivative amino acid pale koʻikoʻi e hele ana i ka deprotection a me ka hoʻāla ʻana no ka hoʻopili ʻana me nā waikawa amino ʻē aʻe e hana i nā kaulahao peptide. Hōʻoia kēia hui i ka hoʻokumu ʻana o nā moʻo peptide kikoʻī e hōʻike ana i ka hana olaola a i ʻole ka hiki ke therapeutic. He mea nui ka maʻemaʻe mau a me ke kūpaʻa o ka hui no ka hōʻoia ʻana i nā hopena hiki ke hana hou ʻia i ka synthesis peptide, e kōkua ana i ka hoʻomohala ʻana o nā moho lāʻau lapaʻau hou a me nā hui bioactive. Eia kekahi, ʻo ka hoʻohālikelike ʻana o H-Tyr(Bzl)-OBzl·Tos me nā ʻano synthesis solid-phase e hiki ai i kona hoʻokomo pono ʻana i loko o nā synthesizers peptide automated, e hoʻomaʻamaʻa ana i ka hana ʻana o nā peptides maʻamau a me nā hale waihona puke peptide no ka ʻike ʻana i nā lāʻau lapaʻau a me nā noi noiʻi. ʻO kāna kuleana i ka hoʻoulu ʻana i nā ʻano peptide like ʻole e lilo ia i mea hana waiwai no ka hoʻoponopono ʻana i nā pilikia biomedical like ʻole a me ka ʻimi ʻana i nā ala hou no nā hana therapeutic. Ma keʻano holoʻokoʻa, ʻo ke koʻikoʻi o H-Tyr(Bzl)-OBzl·Tos i ka synthesis peptide e hoʻonui ana ma o ka noiʻi lāʻau lapaʻau, biotechnology, a me ke kemika lāʻau lapaʻau, kahi e hoʻomau ai i ka hoʻomaʻamaʻa ʻana i ka hoʻokumu ʻana o nā therapeutics peptide-based hou a me nā biopharmaceuticals, e hoʻokele ana i nā holomua i ka mālama ola a me nā ʻepekema ola.
| Hoʻonohonoho ʻana | C30H31NO6S |
| Hoʻāʻo | 99% |
| helehelena | pauka keʻokeʻo |
| Helu CAS. | 66009-35-6 |
| Hoʻopili ʻana | Liʻiliʻi a nui |
| Ola Papa | 2 mau makahiki |
| Ka Waihona | E mālama i kahi maloʻo a me kahi anuanu |
| Palapala hōʻoia | ISO. |





![ʻAkika D-erythro-Hexonic, 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-, 1,1-dimethylethyl ester CAS:1326302-97-9](https://cdn.globalso.com/xindaobiotech/5MP5Q8ON1L0US5UO@7T25.png)


